Related references
Note: Only part of the references are listed.Effective-component compatibility of Bufei Yishen formula II inhibits mucus hypersecretion of chronic obstructive pulmonary disease rats by regulating EGFR/PI3K/mTOR signaling
Jiansheng Li et al.
JOURNAL OF ETHNOPHARMACOLOGY (2020)
Inflammatory mechanisms in patients with chronic obstructive pulmonary disease
Peter J. Barnes
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2016)
Efficacy-oriented compatibility for component-based Chinese medicine
Jun-hua Zhang et al.
ACTA PHARMACOLOGICA SINICA (2015)
Systems pharmacology-based dissection of mechanisms of Chinese medicinal formula Bufei Yishen as an effective treatment for chronic obstructive pulmonary disease
Jiansheng Li et al.
SCIENTIFIC REPORTS (2015)
Long-term effects of three Tiao-Bu Fei-Shen therapies on NF-κB/TGF-β1/smad2 signaling in rats with chronic obstructive pulmonary disease
Ya Li et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2014)
Cellular and Molecular Mechanisms of Chronic Obstructive Pulmonary Disease
Peter J. Barnes
CLINICS IN CHEST MEDICINE (2014)
Antitumor effects of dammarane-type saponins from steamed Notoginseng
Fan He et al.
PHARMACOGNOSY MAGAZINE (2014)
Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD
Antonino Di Stefano et al.
THORAX (2014)
The effective evaluation on symptoms and quality of life of chronic obstructive pulmonary disease patients treated by comprehensive therapy based on traditional Chinese medicine patterns
Jian-sheng Li et al.
COMPLEMENTARY THERAPIES IN MEDICINE (2013)
Increased phosphorylated p38 mitogen-activated protein kinase in COPD Lungs
Kate Gaffey et al.
EUROPEAN RESPIRATORY JOURNAL (2013)
Effects of comprehensive therapy based on traditional Chinese medicine patterns in stable chronic obstructive pulmonary disease: a four-center, open-label, randomized, controlled study
Su-yun Li et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2012)
p38 MAPK inhibitors, IKK2 inhibitors, and TNFα inhibitors in COPD
Audreesh Banerjee et al.
CURRENT OPINION IN PHARMACOLOGY (2012)
Ginsenoside Rh1 inhibits the invasion and migration of THP-1 acute monocytic leukemia cells via inactivation of the MAPK signaling pathway
Yeo-Jin Choi et al.
FITOTERAPIA (2011)
Icariin attenuates LPS-induced acute inflammatory responses: Involvement of PI3K/Akt and NF-κB signaling pathway
Chang-Qing Xu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)